Latest filing published 05 Feb 2026 for ProMIS Neurosciences Inc., €68k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -45.2%Entry US$13.50 · Close at T+90 US$7.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Max A. Milbury: trading record in brief
Max A. Milbury appears in our data through filings on ProMIS Neurosciences Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 23 August 2023 and the latest from 3 February 2026.
Every open-market trade on record is a purchase: 1 purchase worth €13k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants.
Most recently, on 5 February 2026, the filings show a share grant worth €68k in ProMIS Neurosciences Inc. The last purchase on record was published on 6 October 2025, which is 398 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Max A. Milbury
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,595 shares@ US$12.1384.2% of flowCommon SharesSEC:0001104659-26-011137:0
- 30,392 shares@ US$0.491215.8% of flowCommon SharesSEC:0001927056-25-000004:0Canonical exit: 1 Jan 2026 (T+90)
- 13,297 sharesCommon SharesSEC:0000899243-23-018461:0
3 of 3 declarations